Neugebauer, Volker, Ping-Sun Chen, and William D. Willis. Groups II and III metabotropic glutamate receptors differentially modulate brief and prolonged nociception in primate STT cells. J Neurophysiol 84: 2998 -3009, 2000. The heterogeneous family of G-protein-coupled metabotropic glutamate receptors (mGluRs) provides excitatory and inhibitory controls of synaptic transmission and neuronal excitability in the nervous system. Eight mGluR subtypes have been cloned and are classified in three subgroups. Group I mGluRs can stimulate phosphoinositide hydrolysis and activate protein kinase C whereas group II (mGluR2 and 3) and group III (mGluR4, 6, 7, and 8) mGluRs share the ability to inhibit cAMP formation. The present study examined the roles of groups II and III mGluRs in the processing of brief nociceptive information and capsaicin-induced central sensitization of primate spinothalamic tract (STT) cells in vivo. In 11 anesthetized male monkeys (Macaca fascicularis), extracellular recordings were made from 21 STT cells in the lumbar dorsal horn. Responses to brief (15 s) cutaneous stimuli of innocuous (brush), marginally and distinctly noxious (press and pinch, respectively) intensity were recorded before, during, and after the infusion of group II and group III mGluR agonists into the dorsal horn by microdialysis. Different concentrations were applied for at least 20 min each (at 5 l/min) to obtain cumulative concentration-response relationships. Values in this paper refer to the drug concentrations in the microdialysis fibers; actual concentrations in the tissue are about three orders of magnitude lower. The agonists were also applied at 10 -25 min after intradermal capsaicin injection. The group II agonists (2S,1ЈS,2ЈS)-2-(carboxycyclopropyl)glycine (LCCG1, 1 M-10 mM, n ϭ 6) and (Ϫ)-2-oxa-4-aminobicyclo[3.1.0]hexane-4,6-dicarboxylate (LY379268; 1 M-10 mM, n ϭ 6) had no significant effects on the responses to brief cutaneous mechanical stimuli (brush, press, pinch) or on ongoing background activity. In contrast, the group III agonist L(ϩ)-2-amino-4-phosphonobutyric acid (LAP4, 0.1 M-10 mM, n ϭ 6) inhibited the responses to cutaneous mechanical stimuli in a concentration-dependent manner, having a stronger effect on brush responses than on responses to press and pinch. LAP4 did not change background discharges significantly. Intradermal injections of capsaicin increased ongoing background activity and sensitized the STT cells to cutaneous mechanical stimuli (ongoing activity Ͼ brush Ͼ press Ͼ pinch). When given as posttreatment, the group II agonists LCCG1 (100 M, n ϭ 5) and LY379268 (100 M, n ϭ 6) and the group III agonist LAP4 (100 M, n ϭ 6) reversed the capsaicin-induced sensitization. After washout of the agonists, the central sensitization resumed. Our data suggest that, while activation of both group II and group III mGluRs can reverse capsaicin-induced central sensitization, it is the actions of group II mGluRs in particular that undergo significant functional changes during central sensitiza-Address for reprint requests:
tion because they modulate responses of sensitized STT cells but have no effect under control conditions. I N T R O D U C T I O N G-protein-coupled metabotropic glutamate receptors (mGluRs) play important roles in various forms of neuroplasticity and are becoming novel therapeutic targets for certain neurological and psychiatric disorders associated with neuroplastic changes (Bordi and Ugolini 1999; Conn and Pin 1997; Knöpfel et al. 1995; Nicoletti et al. 1996) . The heterogeneous mGluR family consists of eight cloned subtypes, which are classified into three groups. Group I receptors (mGluRs 1 and 5) couple to phospholipase C and regulate neuronal excitability and synaptic transmission. Group II (mGluRs 2 and 3) and group III (mGluRs 4, 6, 7, and 8) receptors inhibit adenylyl cyclase and reduce neuronal excitability and synaptic transmission (Bushell et al. 1999; Conn and Pin 1997; Gereau and Conn 1995; Knöpfel et al. 1995; Macek et al. 1996; Miller 1998; Neugebauer et al. 1997 Neugebauer et al. , 2000 Schoepp et al. 1999; Schoppa and Westbrook 1997; Schrader and Tasker 1997) .
An emerging field of research implicates mGluRs in nociception and hyperalgesia. Whereas the first reports on the involvement of mGluRs in spinal nociceptive processing relied on a relatively nonselective mGluR antagonist (Neugebauer et al. 1994; Young et al. 1994) , recent electrophysiological and behavioral studies used more selective agents to demonstrate a role of group I mGluRs and, in particular, the mGluR1 subtype in prolonged nociception in the spinal cord (Budai and Larson 1997; Fisher and Coderre 1996; Fundytus et al. 1998; Neugebauer et al. 1999; Young et al. 1997 Young et al. , 1998 .
The role of group II and group III mGluRs in the modulation of spinal nociceptive processes is not clear yet. Activation of these receptors has been shown to inhibit neuronal excitability and synaptic transmission in many brain areas (see references in Conn and Pin 1997; Knöpfel et al. 1995; Miller 1998; Neugebauer et al. 1997; Pin and Duvoisin 1995; Schoepp et al. 1999) as well as in spinal cord in vitro preparations (Cao et al. 1997; Dong and Feldman 1999; Jane et al. 1996; King and Liu 1996) . With regard to nociception, an electrophysiological study of wide-dynamic-range (WDR) spinal dorsal horn neurons in vivo described inhibitory effects of a group II mGluR agonist on C-fiber-evoked discharges in rats with carrageenan inflammation, whereas mixed (excitatory or inhibitory) effects were observed in control rats without inflammation (Stanfa and Dickenson 1998) . A behavioral study found that the nociceptive responses in the second phase of the formalin test were potentiated by a group II agonist but slightly reduced by a group III agonist (Fisher and Coderre 1996) .
The present electrophysiological study of primate spinothalamic tract (STT) cells is the first to address the role of group II and group III mGluRs in brief nonnociceptive and nociceptive transmission and in prolonged nociception evoked by intradermal capsaicin. Intradermal injection of capsaicin in humans results in primary mechanical and thermal hyperalgesia at the injection site as well as in secondary mechanical hyperalgesia (increased pain from noxious stimuli) and mechanical allodynia (pain evoked by innocuous stimuli) in an area surrounding the zone of primary hyperalgesia Simone et al. 1991) . Primate STT neurons develop enhanced responses to cutaneous mechanical stimuli and increased background activity after intradermal capsaicin injection Simone et al. 1991 ). Central nervous system changes, termed central sensitization, are believed to underlie capsaicin-induced secondary hyperalgesia and allodynia since afferent nerve fibers supplying the area outside of primary hyperalgesia zone do not sensitize (Baumann et al. 1992; LaMotte et al. 1992) .
Capsaicin-induced central sensitization of STT cells involves the activation of N-methyl-D-aspartate (NMDA) and non-NMDA glutamate receptors, group I metabotropic glutamate receptors of the mGluR1 subtype, and neurokinin 1 and 2 receptors (Dougherty et al. , 1994 Neugebauer et al. 1999; Rees et al. 1998) . Intracellular signal transduction systems such as the protein kinase C (PKC), cAMP-dependent protein kinase A (PKA), and the nitric-oxide-activated cGMPdependent protein kinase G (PKG) pathways also play important roles in the sensitization of STT neurons after intradermal capsaicin (Lin et al. 1996b (Lin et al. , 1997 (Lin et al. , 1999 Sluka 1997a; Sluka and Willis 1998; Wu et al. 1998) .
Activation of the G-protein-coupled group II and group III mGluRs has been shown to inhibit cAMP formation in expression systems, brain slices, and neuronal cultures (Conn and Pin 1997; Pin and Duvoisin 1995; Schoepp et al. 1999) . It is not clear, however, whether group II and/or group III mGluRs actually couple to inhibition of neurotransmitter-induced cAMP increases in native systems. If so, agonists at these receptors may be useful in downregulating the enhanced responses of nociceptive neurons in those instances of central sensitization that involve the cAMP-PKA pathway. The functional role of group II and group III mGluRs in spinal nociceptive processing and central sensitization was addressed in the present study. In anesthetized monkeys, extracellular recordings were made from STT cells. The responses to brief cutaneous stimuli were tested before, during, and after the application of selective group II and group III mGluR agonists into the dorsal horn by microdialysis. Cumulative concentration-responses curves were measured. The agonists were also applied 10 -25 min after intradermal injections of capsaicin to analyze the potential usefulness of agents targeting groups II and III mGluRs in the treatment of prolonged pain associated with central sensitization. Preliminary results have been reported in abstract form (Chen et al. 1998) .
M E T H O D S

Animal preparation and anesthesia
Adult male monkeys (Macaca fascicularis, n ϭ 11, 2.1-2.9 kg) were initially tranquilized with ketamine (10 mg/kg im). Anesthesia was induced with a mixture of halothane, nitrous oxide, and oxygen followed by ␣-chloralose (60 -90 mg/kg iv) and maintained by continuous intravenous infusion of pentobarbital sodium (5 mg ⅐ kg Ϫ1 ⅐ h Ϫ1 ). After a tracheotomy, animals were paralyzed with pancuronium (0.4 -0.5 mg/h iv) and ventilated artificially to maintain the end-tidal CO 2 between 3.5 and 4.5%. A bilateral pneumothorax minimized movements caused by respiration. Arterial oxygen saturation was monitored with a rectal oxymeter probe and kept between 96 and 100%. Throughout the experiment, the level of anesthesia was monitored by frequently examining pupillary size and reflex responses and by continuously recording CO 2 levels and electrocardiogram (ECG). Core body temperature was kept at ϳ37°C using a thermostatically controlled heating blanket. A laminectomy exposed the lumbar enlargement. A pool was formed with the skin flaps overlying the cord and filled with mineral oil, which was kept at 37°C using a heating device. The dura mater was opened and reflected to expose the cord. A craniotomy was performed for stereotaxic placement of a monopolar stimulating electrode into the ventroposterolateral (VPL) nucleus of the thalamus. The stereotaxic coordinates were: A: 8 mm; L: 8 mm; 16 -18 mm from the cortical surface. To ensure correct placement, the thalamic electrode was initially used to record the potentials evoked by electrical stimulation of the contralateral dorsal columns and responses to cutaneous stimulation of the contralateral hind limb.
Microdialysis
For drug application, three microdialysis fibers (Spectrum Scientific, 18-kDa cutoff) were positioned in the lumbar enlargement in areas most responsive to stimulation of the lower hindlimb. The fibers were made from Cuprophan tubing (150 m ID; wall thickness, 9 m). The tubing was coated with a thin layer of silicone rubber (3140RTN, Dow Corning) except for a 1-mm-wide gap that was positioned in the gray matter of the ipsilateral spinal dorsal horn. Each fiber was pulled through the spinal cord just below the dorsal root entry zone using a stainless steel pin cemented in the fiber lumen. The fibers were placed in different segments of the lumbar enlargement (L 5 -L 7 ), about 10 mm apart. Using polyethylene tubing, the microdialysis fibers were connected to a syringe seated in a Harvard infusion pump and were continuously perfused with artificial cerebrospinal fluid (ACSF), containing (in mM) 125.0 NaCl, 2.6 KCl, 2.5 NaH 2 PO 4 , 1.3 CaCl 2 , 0.9 MgCl 2 , 21.0 NaHCO 3 , and 3.5 glucose, at a rate of 5 l/min. The ACSF was oxygenated and equilibrated to pH 7.4 with a mixture of 95% O 2 -5% CO 2 . In the beginning of each experiment, ACSF was pumped through the fibers for at least 2 h to allow the neurochemical milieu to reach equilibrium.
Administration of drugs
After stable control responses of a neuron were recorded during administration of ACSF into the dorsal horn for 0.5-1.5 h, the following drugs (concentrations given in parentheses) were administered by microdialysis at 5 l/min for 20 -30 min through the fiber closest to the recorded STT neuron (for mGluR subgroup selectivity of the compounds, see Cartmell et al. 1999 Cartmell et al. , 2000 Conn and Pin 1997; Monn et al. 1999; Schoepp et al. 1999 ): (2S,1ЈS,2ЈS)-2-(carboxycyclopropyl)glycine (LCCG1, a traditional group II mGluR agonist; 1 M to 10 mM); (Ϫ)-2-oxa-4-aminobicyclo[3.1.0]hexane-4,6-dicarboxylate (LY379268, a novel potent and selective group II mGluR agonist; 1 M to 10 mM); L(ϩ)-2-amino-4-phosphonobutyric acid (LAP4, a potent and selective key group III mGluR agonist; 0.1 M to 10 mM). LCCG1 and LAP4 were purchased from Tocris. LY379268 was a generous gift from Eli Lilly. Stock solutions (100 mM) were prepared that were diluted in ACSF to the indicated final concentrations on the day of the experiment. Numbers given throughout this paper refer to the drug concentrations within the microdialysis fiber. The amount of drug diffusing across the dialysis membrane was estimated in vitro. These experiments have shown that in a chamber containing 100 l ACSF the concentration of these drugs is about 1-3% of that being perfused at a rate of 5 l/min for 30 min. It is estimated that due to diffusion in the tissue the concentration reached at the recorded neuron is another order of magnitude lower, i.e., about 1/1,000 of the drug concentration in the microdialysis fiber (see Benveniste and Huttemeier 1990; Neugebauer et al. 1999; Sorkin et al. 1988 ).
Recording of STT cells
STT neurons were recorded extracellularly in the lumbar enlargement of the spinal cord using carbon filament electrodes (resistance: 4 M⍀). Cells were recorded within 0.5-1 mm of a microdialysis fiber to ensure that the drugs administered by microdialysis would reach the neuron in a short period of time at a sufficient concentration. Single STT neurons were isolated following antidromic activation from the contralateral VPL nucleus by square-wave current pulses (1 Hz, 1 mA, 200 s) as described previously . Criteria for antidromic activation were as follows (see Trevino et al. 1973) : constant latency of the evoked spike; ability to follow highfrequency (333-500 Hz) stimulation; and collision of orthodromic spikes with antidromic spikes. The extracellularly recorded signals were amplified and displayed on analog and digital storage oscilloscopes. Signals were also fed into a window discriminator whose output was processed by an interface (CED 1401) connected to a Pentium PC. Spike2 software (CED) was used to create peristimulus rate histograms on-line and to store and analyze digital records of single-unit activity off-line. Throughout the experiment spike size and configuration were continuously monitored on the digital oscilloscope and with the use of Spike2 software to confirm that the same neuron was recorded and that the relationship of the recording electrode to the neuron remained constant.
Experimental protocol
Once an STT cell was identified and isolated, ongoing background activity and responses to graded mechanical stimuli were recorded, and the cutaneous receptive field in the hindlimb was mapped. Cells were characterized by their responses to the following stimuli applied to the most responsive sites in the receptive field: brush (brushing the skin with a soft-hair artist's brush in a stereotyped manner), press (firm pressure using a large arterial clip to apply 1,005 g/8 mm 2 , which is marginally painful when applied to the skin in humans), and pinch (using a small arterial clip to apply 2,660 g/4 mm 2 , which is clearly painful without causing overt damage to the skin). All cells included in this study were WDR STT cells, which responded consistently to innocuous stimuli but were more strongly activated by noxious stimuli.
The stimuli were delivered at three to five test points chosen to span the receptive field. Each stimulus was applied for 15 s followed by a 15-s pause before the next test site was stimulated. To minimize a potential "human factor" bias, the experimenter who applied the mechanical stimuli did not observe the oscilloscope or the computer monitor and was unaware of the response magnitude. The entire sequence of mechanical stimuli (brush, press, and pinch) was repeated three times before drug application and before capsaicin injection, respectively. The stimuli were also applied during and after the application of different drug concentrations and after capsaicin injection. Capsaicin (0.1 ml, diluted in Tween 80 and saline at 3%) was injected intradermally between two test sites at the most responsive portion of the receptive field. Care was taken that the test stimuli were applied to areas away from the capsaicin injection site, i.e., in the zone of secondary hyperalgesia.
Data analysis
Recorded activity was analyzed off-line from peristimulus rate histograms using Spike2 software. Background activity was subtracted from the evoked responses. The effects of drugs and capsaicin on the responses to cutaneous mechanical stimuli were similar for the selected test sites (see Figs. 1, 2, and 4) . Therefore the responses evoked from the different stimulation sites were averaged for each of the mechanical stimuli (brush, press, pinch). All averaged values are given as the means Ϯ SE. Cumulative concentration-response relations were constructed by averaging the mean frequency of the responses for each drug concentration; the averages were then expressed as percentage of predrug control values (set to 100%). EC 50 s and the respective 95% confidence intervals were calculated from sigmoid curves fitted to the cumulative concentration-response data using the FIG. 1. (2S,1ЈS,2ЈS)-2-(carboxycyclopropyl) glycine (LCCG1), a group II metabotropic glutamate receptor (mGluR) agonist, has no significant effects on the ongoing activity and responses of a spinothalamic tract (STT) neuron to brief cutaneous mechanical stimuli. Extracellular recordings from 1 STT neuron of the wide-dynamic-range (WDR) type in the dorsal horn (1,606 M) of the lumbar enlargement. The STT cell could be activated antidromically by electrical stimulation (T ϭ 500 A) in the ventroposterolateral (VPL) nucleus of the thalamus (not shown). Bin width of the histograms in A-C is 0.1 s. A: responses to brief (15 s) graded mechanical stimuli (brush, press, pinch) applied to 3 test points within the cutaneous receptive field (see inset) in the presence of normal artificial cerebrospinal fluid (ACSF) administered by microdialysis into the dorsal horn. B and C: administration of LCCG1 (1 and 10 mM, respectively, dissolved in ACSF) by microdialysis did not alter the responses to mechanical stimuli. following formula for nonlinear regression (Prism 3.0, GraphPad Software, San Diego, CA):
Significance of the effects of LAP4 on ongoing and evoked activity was determined using a repeated-measures ANOVA to analyze the nonlinear concentration-response relationships. An F test (Prism 3.0, GraphPad Software) was used to analyze the linear regression fitted to the concentration-response data for LCCG1 and LY379268 since no successful curve fits were achieved using nonlinear regression analysis. A repeated-measures ANOVA, followed by Newman-Keuls multiple comparison test where appropriate (Prism 3.0, GraphPad Software), was performed on raw data to test for statistical significance of drug effects on capsaicin-induced changes in the responses to the mechanical stimuli and ongoing background activity. Statistical significance was accepted at the level P Ͻ 0.05.
R E S U L T S
Sample of STT neurons
Recordings were made from 21 STT cells of the WDR type in the lumbar enlargements (L 5 -L 7 ) of 11 monkeys. These neurons were recorded at depths of 840 -1,606 m from the dorsal surface of the spinal cord. Based on the correlation between recording depth and laminar position established for STT cells in this laboratory (see Lin et al. 1999) , 15 neurons were in superficial dorsal horn (840 -1,193 m) and 6 neurons were in the deep dorsal horn (1,388 -1,606 m). STT cells were identified by antidromic activation from the VPL nucleus of the thalamus as described in METHODS. The mean threshold for antidromic activation was 449 Ϯ 44 A (150 -740 A); the mean latency was 6.1 Ϯ 0.5 ms (4.0 -10.0 ms). All 21 STT cells had cutaneous receptive fields on the ipsilateral foot, including the toes in 15 cases. The receptive fields of 11 neurons also included parts of the lower leg; 7 of these neurons had cutaneous receptive fields around the knee and on the thigh. Ongoing activity ranged from 1.6 to 33.6 Hz (mean ϭ 9.9 Ϯ 2.5 Hz). Each cell was recorded within 0.5-1 mm of a microdialysis fiber to ensure that the drugs administered by microdialysis reached the neuron in a short period of time at a sufficient concentration. Recordings were conducted no sooner than 3 h following insertion of the microdialysis fiber, which is sufficient time for the stabilization of extracellular neurotransmitter levels (Sorkin and McAdoo 1993; Sorkin et al. 1988 ).
Activation of group III mGluRs, but not group II mGluRs, inhibits the responses of STT cells to brief innocuous and noxious cutaneous mechanical stimuli
GROUP II MGLURS. The modulation of ongoing background activity and of the responses to brush, press, and pinch by group II mGluRs was studied using the agonists LCCG1 (6 STT cells) and LY379268 (6 STT cells). Many previous studies have relied on LCCG1 as a highly potent key group II mGluR agonist with EC 50 values at mGluR2 and mGluR3 in the upper nanomolar range, although higher concentrations of LCCG1 have now been shown to affect other mGluR subtypes as well (see Conn and Pin 1997; Schoepp et al. 1999 ). Therefore in the present study we also tested the novel selective and highly potent group II mGluR agonist LY379268, which demonstrates EC 50 values in the low nanomolar range at mGluR2 and mGluR3 (Cartmell et al. 1999 (Cartmell et al. , 2000 Monn et al. 1999) .
Application of LCCG1 into the dorsal horn by microdialysis had no significant effects on the ongoing activity and responses of STT cells to innocuous and noxious cutaneous stimuli. Figure 1 shows a typical example. The STT neuron was recorded extracellularly in the deep dorsal horn (1,606 M) of the lumbar enlargement. Ongoing activity and responses to graded mechanical stimuli (brush, press, pinch; see METHODS) applied at selected test points of the neuron's cutaneous receptive field (see Fig. 1, inset) were recorded in the presence of normal ACSF administered by microdialysis into the dorsal horn ( Fig. 1A) . Administration of LCCG1 by microdialysis, even at the high concentrations of 1 and 10 mM, did not change ongoing activity or the responses to mechanical stimuli (Fig. 1,  B and C) .
Similarly, the novel group II mGluR agonist LY379368 had no effect on the ongoing background activity and responses of STT neurons to mechanical stimulation of the skin. A typical example is shown in Fig. 2 . This STT neuron was recorded in the superficial dorsal horn (988 M) of the lumbar enlargement. Ongoing activity and responses to graded mechanical stimulation (brush, press, pinch; see METHODS) of the skin at the indicated test points (see Fig. 2 , inset) were recorded in the presence of normal ACSF administered by microdialysis into the dorsal horn ( Fig. 2A ). Administration of relatively high concentrations of LY379368 (1 and 10 mM) by microdialysis did not change ongoing activity and evoked responses of the STT neuron (Fig. 2, B and C) .
Cumulative concentration-response relationships show that neither LCCG1 (up to 10 mM; n ϭ 6; see Fig. 3A ) nor LY379268 (up to 10 mM; n ϭ 6; see Fig. 3B ) altered significantly ongoing activity (ϫ) or the responses to mechanical cutaneous stimuli (brush, press, and pinch represented by different symbols) of STT neurons recorded under control conditions, i.e., in the absence of capsaicin-evoked central sensitization (see Figs. 6 and 7). Linear regression analysis of the concentration-response curves using an F test and the "runs" test, which determines whether the data differ significantly from a straight line (Prism 3.0, GraphPad Software; see METH-ODS) , showed that the slope was not significantly different from zero and the data were not significantly nonlinear (P Ͼ 0.05 in each case). These tests indicate that linear regression analysis was appropriate and there was no significant change of ongoing or evoked activity associated with the different agonist concentrations.
GROUP III MGLURS. In contrast, the selective group III mGluR agonist LAP4 (see Conn and Pin 1997; Schoepp et al. 1999) inhibited the responses to graded mechanical stimuli in a dose-dependent manner without a significant effect on the ongoing discharges. Figure 4 shows extracellularly recorded spikes of one STT neuron in the lumbar spinal dorsal horn (depth 1,030 M). Ongoing activity and the responses to graded mechanical stimulation (brush, press, pinch; see METH-ODS) of selected test points in the neuron's cutaneous receptive field (see Fig. 4 , inset) were recorded in the presence of normal ACSF administered by microdialysis into the dorsal horn ( Fig.  4A ). Administration of LAP4 (100 M) by microdialysis inhibited the responses to brush more than to pinch and press but had no clear effect on ongoing activity (Fig. 4B ). The effects of LAP4 were reversible after washout with normal ACSF by microdialysis (Fig. 4C) . Figure 5 shows the cumulative concentration-response rela-tionships for LAP4 measured in recordings from 6 STT neurons in the lumbar dorsal horn. LAP4 inhibited the responses to brief mechanical cutaneous stimuli (brush, press, pinch; represented by different symbols), but not ongoing background activity (ϫ), in a concentration-dependent manner. Cumulative concentration-response relations were obtained from six WDR STT cells recorded in the lumbar dorsal horn. Cumulative concentration-response relations were constructed by averaging the mean frequency of the responses for each concentration of LAP4; the averages were then expressed as percentage of predrug control values (set to 100%); the EC 50 s were calculated using the formula given in METHODS. LAP4 was more potent in inhibiting the brush responses (EC 50 , 1.0 M; 95% confidence interval, 0.6 -1.9 M) than the responses to press (EC 50 , 5.8 M; 95% confidence interval, 1.0 -35.8 M), and pinch (EC 50 , 4.2 M; 95% confidence interval, 1.7-10.6 M; see METHODS). The effects of LAP4 on the responses to brush, press, and pinch were highly significant (P Ͻ 0.0001 in each case, repeated-measures ANOVA) whereas ongoing background activity was not significantly changed (P ϭ 0.7699, repeated-measures ANOVA).
Group II and III mGluR agonists reverse capsaicin-induced central sensitization in STT cells
The ability of group II and III mGluRs to modulate capsaicin-induced sensitization of STT cells was studied by administering the group II agonists LCCG1 (100 M, 15 min; n ϭ 5) and LY379268 (100 M, 15 min; n ϭ 6) and the group III agonist LAP4 (100 M, 15 min; n ϭ 6) into the spinal dorsal horn at 10 min after intradermal capsaicin (3%) injection. Each agonist was able to reverse the enhanced responses to brush and press following capsaicin. GROUP II MGLURS. Figure 6 shows the typical effects of LCCG1 (A) and LY379268 (B) on two different STT cells. In Fig. 6A , extracellular recordings were made from an STT neuron in the superficial dorsal horn (1,080 M) of the lumbar enlargement. Brief (15 s) graded mechanical stimuli (brush, press, pinch) were applied to the skin of the neuron's receptive field. Consistent with previous studies from this laboratory Simone et al. 1991) , intradermal injection of capsaicin (3%) clearly enhanced the ongoing activity and the responses to brush and press to 252, 192, and 170%, respectively, of the control values before capsaicin; the pinch-evoked responses increased to only 112%. Administration of LCCG1 (100 M; 15 min) into the dorsal horn by microdialysis reduced the enhanced responses almost to the levels before capsaicin. The responses increased again after washout of drug The STT cell could be activated antidromically by electrical stimulation (T ϭ 250 A) in the VPL nucleus of the thalamus (not shown). Bin width of the histograms in A-C is 0.1 s. A: responses to brief (15 s) graded mechanical stimuli (brush, press, pinch) applied to three test points in the cutaneous receptive field (see inset) in the presence of normal ACSF administered by microdialysis into the dorsal horn. B and C: administration of LY379268 (1 and 10 mM, respectively, dissolved in ACSF) by microdialysis had no apparent effect on the responses to mechanical stimuli. FIG. 3. LCCG1 (A, n ϭ 6) and LY379268 (B, n ϭ 6), agonists at group II mGluRs, do not significantly change the ongoing activity (ϫ) and responses of WDR-type STT cells to brief cutaneous mechanical stimuli (brush, press, and pinch; see different symbols). Cumulative concentration-response relationships were obtained by averaging the mean frequency of the responses for each concentration of LCCG1 and LY379268, respectively; the averages were then expressed as percentage of predrug control values (set to 100%). Linear regression analysis of the concentration-response curves using an F test and the "runs" test (see text) showed that the slope was not significantly different from 0 and the data were not significantly nonlinear (P Ͼ 0.05 in A and B) . Values refer to the drug concentrations in the microdialysis fiber; concentration at the recorded neurons is an estimated 3 orders of magnitude lower (see METHODS). Symbols and error bars represent means Ϯ SE.
with normal ACSF and returned to baseline at about 2 h after capsaicin. Without any pre-or posttreatment, the capsaicininduced sensitization of STT cells typically lasts for about 2 h Lin et al. 1999; Simone et al. 1991) . Figure 6B shows the effects of the novel group II mGluR agonist LY379268 on central sensitization in another STT cell recorded at 1,116 M in the superficial dorsal horn of the lumbar enlargement. Ongoing activity and responses to brief (15 s) graded mechanical stimuli (brush, press, pinch) applied to the skin were recorded extracellularly before and after the intradermal injection of capsaicin (3%). The capsaicin injection enhanced the ongoing activity and the responses to brush and press, but not pinch, to 359, 151, 134, and 104%, respectively, of the control values before capsaicin. Administration of LY379268 (100 M; 15 min) into the dorsal horn by microdialysis clearly reduced the enhanced responses. The responses increased again after washout of drug with normal ACSF. Figure 7 summarizes the data for the group II mGluR agonists LCCG1 (A; n ϭ 5) and LY379268 (B; n ϭ 6). Intradermal capsaicin (3%) enhanced ongoing activity (A and B, P Ͻ 0.001) and the responses of STT cells to brush (A, P Ͻ 0.01; B, P Ͻ 0.001), press (A, P Ͻ 0.01; B, P Ͻ 0.001) but not pinch (A and B, P Ͼ 0.05; repeated-measures ANOVA followed by Newman-Keuls multiple comparison test; see METHODS). Application of LCCG1 (100 M; n ϭ 5; Fig. 7A ) into the dorsal horn by microdialysis for 15 min significantly reduced the capsaicin-induced increase of ongoing activity (P Ͻ 0.001) and the enhanced responses to brush (P Ͻ 0.01) and press (P Ͻ 0.01; repeated-measures ANOVA followed by Newman-Keuls multiple comparison test). Similarly, LY379268 (100 M; n ϭ 6; Fig. 7B ) administered into the dorsal horn by microdialysis for 15 min significantly reduced the enhanced ongoing activity (P Ͻ 0.001) and the responses to brush (P Ͻ 0.001) and press (P Ͻ 0.001; repeated-measures ANOVA followed by Newman-Keuls multiple comparison test). After washout of LCCG1, ongoing activity and responses to brush and press increased again significantly at 60 min post capsaicin (P Ͻ 0.05, compared with the values during drug administration at 25 min post capsaicin; P Ͻ 0.05-0.001, compared with control values before capsaicin; repeated-measures ANOVA followed by Newman-Keuls multiple comparison test). Similarly, after washout of LY379268 ongoing activity and brush-and pressevoked responses increased again and were significantly different from the control values before capsaicin (P Ͻ 0.05; repeated-measures ANOVA followed by Newman-Keuls multiple comparison test). The responses to brush and press at 60 min post capsaicin were also significantly different from the FIG. 4. The group III mGluR agonist L(ϩ)-2amino-4-phosphonobutyric acid (LAP4) inhibits the brush responses more than the pinch and press responses. Extracellular recordings from 1 STT neuron in the lumbar spinal dorsal horn (depth: 1,030 M). The STT cell could be activated antidromically by electrical stimulation (T ϭ 350 A) in the VPL nucleus of the thalamus (not shown). Brief (15 s) graded mechanical cutaneous stimuli were applied at the indicated points of the neuron's receptive field (see inset). Bin width of the histograms in A-C is 0.1 s. A: responses to brush, press, and pinch stimuli in the presence of normal ACSF administered by microdialysis into the dorsal horn. B: administration of LAP4 (100 M dissolved in ACSF) by microdialysis inhibited the responses to brush, press, and press without a clear effect on ongoing activity. C: effects of LAP4 were reversible after washout with normal ACSF by microdialysis.
FIG. 5. The group III mGluR agonist LAP4 inhibits the responses to brief mechanical cutaneous stimuli (brush, press, pinch; represented by different symbols), but not ongoing background activity (ϫ), in a concentration-dependent manner. Cumulative concentration-response relationships were obtained from 6 WDR STT cells recorded in the lumbar dorsal horn. Cumulative concentration-response relations were constructed by averaging the mean frequency of the responses for each concentration of LAP4; the averages were then expressed as percentage of predrug control values (set to 100%); the EC 50 s were calculated using the formula given in METHODS. Values refer to the drug concentrations in the microdialysis fiber; concentration at the recorded neurons is an estimated 3 orders of magnitude lower (see METHODS). Symbols and error bars represent means Ϯ SE. responses during drug administration at 25 min (P Ͻ 0.01 and P Ͻ 0.05, respectively; repeated-measures ANOVA followed by Newman-Keuls multiple comparison test). The increase of ongoing activity and evoked responses after washout of the agonists suggests that the inhibition of capsaicin-induced spinal sensitization in these STT cells was due to the drug effects and not the decay of capsaicin-induced sensitization. The similarity of the inhibitory effects obtained with each agonist suggests that the inhibition of capsaicin-induced spinal sensitization involved the group II mGluRs. GROUP III MGLURS. The group III agonist LAP4 was also able to reverse capsaicin-induced central sensitization in STT cells as shown in Fig. 8 . Ongoing activity and responses to graded mechanical stimuli (brush, press, pinch) were recorded extracellularly from an STT cell in the superficial dorsal horn (840 M) of the lumbar enlargement. Intradermal injection of cap-saicin (3%) clearly enhanced ongoing background activity and the responses to brush and press to 187, 245, and 164%, respectively, of the control values before capsaicin. Pinch responses increased to only 111%. Administration of LAP4 (100 M; 15 min) into the dorsal horn by microdialysis at 10 min post capsaicin reversed the increase in ongoing activity and reduced the enhanced brush and press responses to below the control level before capsaicin. Ongoing activity and evoked responses increased again after washout of drug with normal ACSF and showed a decline toward baseline levels at about 2 h after capsaicin. Figure 9 summarizes the data for the group III mGluR FIG. 7. Summary of the inhibition of capsaicin-induced central sensitization by the group II mGluR agonists LCCG1 (A; n ϭ 5) and LY379268 (B; n ϭ 6). In both samples of STT cells (A and B) , intradermal capsaicin (3%) enhanced ongoing activity and responses to brush and press, but not pinch, significantly. A: application of LCCG1 (100 M; n ϭ 5) into the dorsal horn by microdialysis for 15 min significantly reduced the capsaicin-induced increase of ongoing activity and responses to brush and press. B: similarly, LY379268 (100 M; n ϭ 6) administered into the dorsal horn by microdialysis for 15 min significantly reduced the enhanced ongoing activity and responses to brush and press. A and B: after washout of LCCG1 and LY379268, respectively, ongoing activity and responses to brush and press increased again at 60 min post capsaicin and were significantly different from the control values before capsaicin. brush-and press-evoked responses at 60 min post capsaicin were also significantly different from the responses during drug administration at 25 min, suggesting that the inhibition of capsaicin effects was due to the drug effects and not the decay of capsaicin-induced sensitization. In each sample of neurons (A and B) , ongoing activity and evoked responses recorded at the indicated times after capsaicin were averaged and expressed as percentage of the ongoing activity and evoked responses in the control period before capsaicin, which were averaged and set to 100%. *P Ͻ 0.05, **P Ͻ 0.01, ***P Ͻ 0.001, compared with control values before capsaicin; ϩ P Ͻ 0.05, ϩϩ P Ͻ 0.01, ϩϩϩ P Ͻ 0.001, compared with 12 min postcapsaicin; 0 P Ͻ 0.05, 00 P Ͻ 0.01, ongoing activity and evoked responses at 25 min compared with 60 min post capsaicin (repeated-measures ANOVA performed on raw data followed by Newman-Keuls multiple comparison test; see METHODS). Columns and error bars represent means Ϯ SE. (brush, press, pinch) . Intradermal injection of capsaicin (3%) enhanced the responses to brush (E) and press (•) as well as ongoing activity (ϫ); only a slight increase of the pinch-evoked responses (Ⅲ) was observed. Administration of LCCG1 (100 M; 15 min) into the dorsal horn by microdialysis reduced the enhanced responses almost to the levels before capsaicin. Ongoing and evoked activity increased again after washout of drug with normal ACSF and returned to baseline at ϳ 2 h after capsaicin. B: recordings of ongoing activity and responses of 1 WDR STT neuron (1,116 M) to cutaneous mechanical stimuli (brush, press, pinch). Intradermal injection of capsaicin (3%) strongly enhanced ongoing activity (ϫ) and the responses to brush (E) and press (•). Administration of LY379268 (100 M; 15 min) into the dorsal horn by microdialysis reversed the potentiating effects of capsaicin. Ongoing activity and evoked responses increased again after washout of drug with normal ACSF and remained elevated until ϳ 2 h after capsaicin. A and B: each symbol represents the number of spikes per second. Ongoing activity has been subtracted from the evoked response. agonist LAP4 (n ϭ 6). Intradermal capsaicin (3%) significantly enhanced ongoing activity (P Ͻ 0.01) and the responses of STT cells to brush (P Ͻ 0.01) and press (P Ͻ 0.05) but not pinch (P Ͼ 0.05; repeated-measures ANOVA followed by Newman-Keuls multiple comparison test; see METHODS). Administration of LAP4 (100 M, 15 min; n ϭ 6) into the dorsal horn by microdialysis post capsaicin significantly reduced the enhanced responses to brush (P Ͻ 0.001) and press (P Ͻ 0.01; repeated-measures ANOVA followed by Newman-Keuls multiple comparison test). LAP4 also reduced the increased ongoing activity in three of six neurons, but this effect did not reach the level of statistical significance in the whole sample of neurons (P Ͼ 0.05). Although the pinch-evoked responses were not significantly enhanced by capsaicin, LAP4 significantly inhibited the responses to pinch in four of six neurons (P Ͻ 0.05; repeated-measures ANOVA followed by Newman-Keuls multiple comparison test), resembling its effects in the absence of central sensitization (see Figs. 4 and 5) . After washout of LAP4, the responses to brush, press, and pinch increased again significantly at 60 min post capsaicin (P Ͻ 0.001, P Ͻ 0.01, P Ͻ 0.05, respectively, compared with 25 min post capsaicin; repeated-measures ANOVA followed by Newman-Keuls multiple comparison test). Ongoing activity also increased at 60 min post capsaicin but was not significantly different from the values during drug application at 25 min post capsaicin (P Ͼ 0.05). The rebound of capsaicin effects after washout of LAP4 suggests that the inhibition of capsaicininduced sensitization in these STT cells was due to drug effects and not the decay of capsaicin-induced sensitization.
D I S C U S S I O N
This study addressed in primate STT cells the role of groups II and III mGluRs in brief nonnociceptive and nociceptive transmission and in central sensitization evoked by intradermal capsaicin. The major findings are as follows. 1) Administration of group II mGluR agonists into the spinal dorsal horn had no significant effect on ongoing background activity or responses to brief cutaneous mechanical stimuli. 2) Intraspinal administration of a group III agonist, however, reduced the responses to innocuous and noxious mechanical stimuli without a significant effect on background activity. 3) When given as posttreatment in capsaicin-induced central sensitization, the group II mGluR agonists now inhibited the enhanced responses to brush and press and background activity. 4) Posttreatment with the group III agonist inhibited the enhanced responses to brush and press and, in some cases, pinch. These data suggest that in central sensitization of primate STT cells the functional role of group II mGluRs changes substantially, whereas the effects mediated by group III mGluRs remain largely unchanged.
The interpretation of our findings relies on the selectivity and appropriate concentrations of the mGluR agonists we used. The group II agonist LCCG1 has been used in many previous studies as a highly potent agonist at mGluR2 and mGluR3 subtypes (see Conn and Pin 1997; Schoepp et al. 1999) . We tested LCCG1 so that our results can be compared with those studies. Since higher concentrations of LCCG1 have been shown to affect other mGluR subtypes as well (see , we also tested the novel potent and selective group II mGluR agonist LY379268. LY379268 has a nanomolar affinity and potency at mGluR2 and mGluR3 and shows a more than 1,000-fold selectivity for group II mGluRs over other mGluR subtypes (Cartmell et al. 1999 (Cartmell et al. , 2000 Monn et al. FIG. 9 . Summary of the inhibition of capsaicin-induced central sensitization by the group III mGluR agonist LAP4 (n ϭ 6). Intradermal capsaicin (3%) significantly enhanced ongoing activity and the responses of STT cells to brush and press but not pinch. Application of LAP4 into the dorsal horn by microdialysis post capsaicin significantly reduced the enhanced responses to brush and press. LAP4 also inhibited the responses to pinch in 4 neurons. Inhibition of ongoing activity by LAP4 was seen in 3 of 6 neurons but did not reach the level of significance in the whole sample of neurons. After washout of LAP4, evoked responses increased again significantly at 60 min post capsaicin, suggesting that the inhibition of capsaicin-induced sensitization in these STT cells was due to drug effects and not the decay of capsaicin-induced sensitization. Ongoing activity also increased at 60 min post capsaicin but was not significantly different from the values during drug application at 25 min post capsaicin. Ongoing activity and evoked responses recorded at the indicated times after capsaicin were averaged and expressed as percentage of the ongoing activity and evoked responses in the control period before capsaicin, which were averaged and set to 100%. *P Ͻ 0.05, **P Ͻ 0.01, compared with control values before capsaicin; ϩ P Ͻ 0.05, ϩϩ P Ͻ 0.01, ϩϩϩ P Ͻ 0.001, compared with 12 min postcapsaicin; 0 P Ͻ 0.05, 00 P Ͻ 0.01, 000 P Ͻ 0.001, ongoing activity and responses at 25 min compared with 60 min post capsaicin (repeated-measures ANOVA performed on raw data followed by Newman-Keuls multiple comparison test; see METHODS). Columns and error bars represent means Ϯ SE. (brush, press, pinch) . Intradermal injection of capsaicin (3%) enhanced the responses to brush (E) and press (•) as well as ongoing activity (ϫ). Effect on the response to pinch (Ⅲ) was less clear. Administration of LAP4 (100 M; 15 min) into the dorsal horn by microdialysis reversed the potentiating effects of capsaicin. Ongoing activity and evoked responses increased again after washout of drug with normal ACSF. Each symbol represents the number of spikes per second. Ongoing activity has been subtracted from the evoked response.
1999). For the study of group III mGluRs, we used LAP4, a potent and selective key agonist for group III mGluRs (Conn and Pin 1997; Pin and Duvoisin 1995; Schoepp et al. 1999) . LCCG1 and LAP4 have been shown by others to inhibit transmitter release in the brain when administered by microdialysis with a time course and at concentrations similar to our study (Cozzi et al. 1997; Hu et al. 1999; Maione et al. 1998) .
Additional evidence suggests that our approach allowed the pharmacological discrimination of groups II and III mGluRs. We used micromolar to low millimolar drug concentrations in the microdialysis fiber, which produce effective nanomolar to low micromolar concentrations in the tissue at the recorded neuron (see METHODS) . Such low concentrations have been shown to be selective in in vitro studies (Conn and Pin 1997; Monn et al. 1999; Schoepp et al. 1999) . We have measured the amount of drug diffusing across the dialysis membrane in vitro to be only 1-3% of the perfused concentration (see METHODS). This concentration decreases by another order of magnitude after diffusion of the drug away from the microdialysis fiber into the dorsal horn close enough to affect the recorded STT neuron (cf. Sorkin et al. 1988 ). Furthermore both group II mGluR agonists, LCCG1 and LY379268, had very similar effects but behaved differently than the group III agonist LAP4 in that the group II agonists had no significant effects under normal conditions, whereas LAP4 reduced the responses to cutaneous mechanical stimuli.
The differential modulation of the responses of nonsensitized STT neurons by group II and group III mGluRs is an unexpected but intriguing finding. It is not clear why group II agonists had no effect under normal conditions. Group II mGluR2 and mGluR3 subtypes have been detected in the dorsal horn at the messenger RNA (Berthele et al. 1999; Ohishi et al. 1993a,b; Valerio et al. 1997 ) and the protein level (Jia et al. 1999; Tang and Sim 1999) . The cellular localization, however, of group II mGluRs in the preterminal area distant from the transmitter-release site rather than on the presynaptic terminals per se ) may play a role in the lack of group II agonist effects we observed. It is also possible that activation of spinal group II mGluRs produces both inhibitory and excitatory effects with the result of a zero net effect. Electrophysiological studies have found excitatory, inhibitory, dual, and mixed effects of group II mGluRs on spinal motoneurons and unidentified dorsal and ventral horn neurons (Bond and Lodge 1995; Bond et al. 1997; Cao et al. 1995 Cao et al. , 1997 Dong and Feldman 1999; King and Liu 1996; Stanfa and Dickenson 1998) . Group II mGluRs can act as auto-as well as hetero-receptors to inhibit glutamatergic and GABAergic synaptic transmission (see Conn and Pin 1997; Miller 1998; Pin and Duvoisin 1995) . STT cells receive both glutamatergic and GABAergic inputs (Lekan and Carlton 1995) and group II mGluRs are present on glutamatergic and GABAergic terminals in the spinal cord (Jia et al. 1999 ). In addition, the combination of group II mGluR-mediated postsynaptic excitation (see Conn and Pin 1997; Miller 1998; Pin and Duvoisin 1995) and postsynaptic inhibition (Dutar et al. 1999; Holmes et al. 1996; Keele et al. 1999; Knoflach and Kemp 1998; Sharon et al. 1997 ) may contribute to a zero net effect of group II agonists.
It is also conceivable that the group II agonists have little effect because the available group II receptors are under some level of activation. The intrathecal application of a group II mGluR antagonist has recently been reported to reduce response thresholds to noxious mechanical stimuli in awake animals, possibly suggesting a tonic group II mGluR component in spinal cord during normal behavior (Dolan and Nolan 2000) . In spinal cord in vitro preparations, presumed group II mGluR antagonists potentiated synaptically evoked responses of spinal motoneurons (Cao et al. 1997 ) but not of neurons in lamina II of the dorsal horn (Chen and Sandkühler 2000) and had no effect on dorsal root-evoked ventral root potentials (Jane et al. 1996) . Another explanation of the lack of group II agonist effects involves the growing body of evidence that mGluR-mediated signal transduction is tightly regulated by the phosphorylation state of the receptor through various kinases (Macek et al. 1999; Peavy et al. 1998; Saugstad et al. 1998; Schaffhauser et al. 2000) . In fact Schaffhauser et al. (2000) have shown that mGluR2 specifically is turned off by PKA. However, previous studies from our lab (Sluka 1997a; and work done by others (Krieger et al. 2000; Malmberg et al. 1997; Ohsawa and Kamei 1999; Wei and Roerig 1998; Young et al. 1995) have not produced any evidence for a significant role of PKA or adenylyl cyclase in normal spinal transmission.
In contrast, the group III agonist LAP4 clearly inhibited the responses of nonsensitized STT cells. Group III mGluRs can function as presynaptic autoreceptors, inhibit adenylyl cyclase, and modulate ion channels (Conn and Pin 1997; Miller 1998; Pin and Duvoisin 1995) . Inhibition of cAMP production is unlikely to be involved in the inhibitory effects of LAP4 on nonsensitized STT cells because neither peripheral nor spinal blockade of the cAMP-PKA pathway affect normal responses and nociceptive thresholds in animals (Ahlgren and Levine 1993; . Further, if cAMP was involved, group II and III agonists should have similar effects since both subgroups couple negatively to adenylyl cyclase. A general reduction of neuronal excitability by activation of potassium currents is also unlikely since LAP4 inhibited only the evoked responses but not ongoing activity.
The stronger inhibition by LAP4 of the brush than the press and pinch responses could involve L-type or both L-and N-type calcium channels. L-and N-type calcium channel blockers reduce the responses of dorsal horn neurons to innocuous and noxious mechanical stimuli with L-type blockers having stronger effects on the nonnociceptive responses (Neugebauer et al. 1996) . LAP4 may also influence transmitter release "downstream" of calcium entry (Bushell et al. 1999) . Differences in the laminar distribution and agonist affinity of the group III subtypes could then explain the stronger effect of LAP4 on the brush responses: mGluR7 has a much lower affinity for glutamate and LAP4 than mGluR4 and is localized on nociceptive afferent terminals in the superficial dorsal horn, whereas the laminar distribution of mGluR4 is consistent with a localization on nonnociceptive primary afferents and spinal interneurons (Kinoshita et al. 1998; Li et al. 1996 Li et al. , 1997 Ohishi et al. 1995a,b) . No other group III subtypes have been detected in the spinal cord (Berthele et al. 1999; Valerio et al. 1997) .
In capsaicin-induced central sensitization, both group II and III agonists inhibited the enhanced responses of STT cells. This effect may be related to inhibition of cAMP accumulation. Both groups of mGluRs are characterized by their negative coupling to adenylyl cyclase (see Conn and Pin 1997; Miller 1998; Pin and Duvoisin 1995; Schoepp et al. 1999) , and blockade of the cAMP-PKA pathway can reduce capsaicininduced mechanical hyperalgesia and allodynia (Sluka 1997a; and central sensitization (Sluka et al. 1997a) . Increased cAMP accumulation can result from the activation of group I mGluRs, especially mGluR1 (see also Conn and Pin 1997) , which plays a crucial role in the capsaicin-induced central sensitization of STT cells .
The dramatic change in the effects of the group II mGluR agonists following intradermal injection of capsaicin may suggest a change in the functional role of group II mGluRs in central sensitization. Similarly, Stanfa and Dickenson (1998) found that the group II agonist 1S,3S-ACPD had mixed inhibitory and excitatory effects on electrically (C-fiber)-evoked activity in dorsal horn neurons in control animals but predominantly inhibitory effects in the carrageenan model. Several mechanisms may account for this change: inhibition of the cAMP-PKA transduction cascade through group II mGluRs in central sensitization but not under normal conditions; upregulation of group II mGluRs in central sensitization; inhibition of high-voltage-activated calcium channels, e.g., P/Q-type channels, which can be inhibited by group II mGluRs (see Conn and Pin 1997; Miller 1998) and are, at the level of the spinal cord, involved in central sensitization but not in normal behavior or neurotransmission (Nebe et al. 1997; Sluka 1997b) ; and imbalance of inhibition of excitatory and inhibitory transmission in central sensitization, which is characterized by an increased glutamatergic transmission combined with a decreased GABAergic tone Lin et al. 1996a ) so that inhibition of excitatory transmission by group II agonists would prevail over disinhibition.
It is important to note that capsaicin-induced central sensitization of STT cells resumed after the group II and group III agonists were washed out. This finding implies some form of tonic activation that attempts to produce central sensitization and is only temporarily blocked by the activation of group II and III mGluRs. Capsaicin-induced central sensitization of STT cells involves a variety of neurotransmitter and neuromodulators (Dougherty et al. , 1994 Neugebauer et al. 1999; Rees et al. 1998 ) and signal transduction pathways (Lin et al. 1996b (Lin et al. , 1997 (Lin et al. , 1999 Sluka 1997a; Sluka and Willis 1998; Wu et al. 1998 ). Since manipulation of each individual component of the sensitization process has profound effects, these elements appear to operate in series rather than in parallel. This hypothesis is consistent with the various welldocumented interactions of ionotropic and metabotropic glutamate receptors, glutamate and neuropeptide receptors, metabotropic glutamate receptors, and second-messenger systems, and among signal transduction pathways in the nervous system (for recent reviews, see Conn and Pin 1997; Herrero et al. 2000; Hobbs et al. 1999; Hollmann and Heinemann 1994; Majewski et al. 1997; Miller 1998; Pin and Duvoisin 1995; Ramakers et al. 1997; Riedel 1997; Ruth 1999; Saria 1999; Sassone-Corsi 1998; Schoepp et al. 1999; Tanaka and Nishizuka 1994; Van Rossum et al. 1997; Willis et al. 1996; Xia and Storm 1997) .
In conclusion, both group II and III agonists inhibit capsaicin-induced central sensitization of STT cells whereas the group III, but not group II, mGluR agonists also affect the responses of nonsensitized neurons. For the treatment of pain states, the ideal drug should be effective in pain-related central sensitization but have no or minimal effects under normal conditions. The present study suggests that group II mGluR agonists may be among those agents. In contrast, group III agonists (this study) and group I antagonists can inhibit central sensitization of STT cells but also affect normal neurotransmission in these neurons. The significant change of the functional role of group II mGluRs in central sensitization suggests that mGluR2 and/or mGluR3 may be useful targets for the development of drugs to relieve persistent pain associated with central sensitization.
